[Use of the S3 guidelines for early detection of prostate cancer in urological practices]
- PMID: 28280863
- DOI: 10.1007/s00120-017-0352-1
[Use of the S3 guidelines for early detection of prostate cancer in urological practices]
Abstract
Objectives: The German S3 guideline on prostate cancer gives recommendations on early detection of prostate cancer. In this study we analyzed the adherence of urologists in private practice from the administrative district of Münster, Germany to this guideline.
Methods: Data were collected through a semistructured survey of 22 urologists based on the COREQ checklist (Consolidated criteria for reporting qualitative research) in four focus groups consisting of five or six urologists in private practice. We developed 23 questions relating to 12 recommendations of the paragraphs of the S3 guidelines dealing with early detection of prostate cancer and prostate biopsy. The recommendations of the guideline are subdivided in nine "strong", one "optional recommendation" and two "statements". The adherence to the guideline was investigated by using frequency and qualitative content analysis (Mayring) based on a mixed methods design.
Results: The urologists follow six of the nine "strong recommendations" of the guideline and deviate from three. Reasons for deviations from "strong recommendations" are the following: information about advantages and disadvantages of early detection for prostate cancer, recommendation of a prostate biopsy in case of PSA level ≥4 ng/ml, and indication for repeat biopsy.
Conclusion: Most of the "strong recommendations" are followed by the interviewed urologists of the administrative district of Münster. Contextually relevant deviations from "strong recommendations" are justified, e. g., the only limited transferability of the PSA threshold of 4 ng/ml derived from population-based studies of asymptomatic men to men presenting in a urologist's office.
Keywords: Adherence; Focus groups; Interview; Prostate biopsy; Prostate cancer.
Similar articles
-
Compliance with biopsy recommendations of a prostate cancer risk calculator.BJU Int. 2012 May;109(10):1480-8. doi: 10.1111/j.1464-410X.2011.10611.x. Epub 2011 Sep 20. BJU Int. 2012. PMID: 21933335 Clinical Trial.
-
Selecting men diagnosed with prostate cancer for active surveillance using a risk calculator: a prospective impact study.BJU Int. 2012 Jul;110(2):180-7. doi: 10.1111/j.1464-410X.2011.10679.x. Epub 2011 Nov 23. BJU Int. 2012. PMID: 22112199
-
[Implementation of the S3 prostate cancer guideline in daily clinical practice: results of a survey among urologists].Urologe A. 2014 Oct;53(10):1500-3. doi: 10.1007/s00120-014-3518-0. Urologe A. 2014. PMID: 24984950 German.
-
[Challenges in prostate biopsies : From the perspective of practicing urologists and professional policy perspective].Urologie. 2023 May;62(5):487-493. doi: 10.1007/s00120-023-02067-8. Epub 2023 Apr 21. Urologie. 2023. PMID: 37083828 Review. German.
-
Guideline of guidelines: prostate cancer screening.BJU Int. 2014 Sep;114(3):323-5. doi: 10.1111/bju.12854. BJU Int. 2014. PMID: 24981126 Review. No abstract available.
Cited by
-
Barriers and facilitators of adherence to clinical practice guidelines in Germany-A systematic review.J Eval Clin Pract. 2025 Apr;31(3):e14173. doi: 10.1111/jep.14173. Epub 2024 Oct 16. J Eval Clin Pract. 2025. PMID: 39415487 Free PMC article.
-
Impact of guideline awareness on the counseling of patients with acute cough among general practitioners and pharmacy personnel.PLoS One. 2021 Aug 5;16(8):e0254086. doi: 10.1371/journal.pone.0254086. eCollection 2021. PLoS One. 2021. PMID: 34351926 Free PMC article.
-
Decision aid and cost compensation influence uptake of PSA-based early detection without affecting decisional conflict: a cluster randomised trial.Sci Rep. 2021 Dec 6;11(1):23503. doi: 10.1038/s41598-021-02696-z. Sci Rep. 2021. PMID: 34873188 Free PMC article. Clinical Trial.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous